SALMON Pharma GmbH 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-15 7:51 pm Unchanged | 2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON | SALMON Pharma GmbH | 50,793 22.400% | 0 (Unchanged) | Filing |
| 2021-02-12 6:02 pm Purchase | 2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON | SALMON Pharma GmbH | 50,793 20.500% | 50,793 (New Position) | Filing |